Alpha-synuclein, Sheep Polyclonal Antibody

As low as US$317.00
Only %1 left
Catalog Number
S-075

    Product Info

  • Product Name Alpha-synuclein, Sheep Polyclonal Antibody
  • Product Description google Sheep anti-Alpha-synuclein Polyclonal Antibody (Unconjugated), suitable for WB, IHC-Frozen, IHC-Paraffin-embedded, ELISA.
  • Alternative Names Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP
  • Application(s) ELISA, IHC-Frozen, IHC-Paraffin-embedded, WB
  • Antibody Host Sheep
  • Antibody Type Polyclonal
  • Specificity This antiserum specifically detects alpha synuclein. This antibody is known to react with alpha synuclein of human, mouse, rat and other rodents.
  • Species Reactivity Human, Mouse, Rat
  • Immunogen Description A synthetic peptide (CMPVDPDNEAYEMPSEE) of human alpha synuclein protein (aa: 116-131) conjugated to diphtheria toxoid has been used as the immunogen.
  • Conjugate Unconjugated
  • Purity Description Affinity purified and dialysed against phosphate buffered saline (PBS).
  • Regulatory Status For research use only.

    Specifications

  • Product Description Sheep anti-Alpha-synuclein Polyclonal Antibody (Unconjugated), suitable for WB, IHC-Frozen, IHC-Paraffin-embedded, ELISA.
  • Application(s) ELISA, IHC-Frozen, IHC-Paraffin-embedded, WB
  • Application Details Immunohistochemistry (IHC): 1-4 µg/mL (paraffin sections)
    Western Blotting (WB): 0.5 - 2.0 µg/mL. Fixing of proteins on membrane with 0.4% formaldehyde (30 min at room temperature) recommended, see Lee & Kamitani, 2011.
    Flow Cytometry: 2 µg antibody per ~10^6 cells, methanol-fixed.
    Immunocytochemistry (ICC): 1-4 µg/mL, 4% formaldehyde-fixed cells.

    Biosensis recommends optimal dilutions/concentrations should be determined by the end user.
  • Target Alpha-synuclein
  • Specificity This antiserum specifically detects alpha synuclein. This antibody is known to react with alpha synuclein of human, mouse, rat and other rodents.
  • Target Host Species Human
  • Species Reactivity Human, Mouse, Rat
  • Antibody Host Sheep
  • Antibody Type Polyclonal
  • Antibody Isotype IgG
  • Conjugate Unconjugated
  • Immunogen Description A synthetic peptide (CMPVDPDNEAYEMPSEE) of human alpha synuclein protein (aa: 116-131) conjugated to diphtheria toxoid has been used as the immunogen.
  • Purity Description Affinity purified and dialysed against phosphate buffered saline (PBS).
  • Format Lyophilized
  • Reconstitution Instructions Spin vial briefly before opening. Reconstitute in 50 µL sterile-filtered, ultrapure water. Centrifuge to remove any insoluble material.
  • Storage Instructions After reconstitution keep aliquots at -20°C for a higher stability, and at 2-8°C with an appropriate antibacterial agent. Glycerol (1:1) may be added for an additional stability. Avoid repetitive freeze/thaw cycles.
  • Batch Number Please see item label.
  • Expiration Date 12 months after date of receipt (unopened vial).
  • Alternative Names Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP
  • Uniprot Number P37840
  • Uniprot Number/Name P37840 (SYUA_HUMAN)
  • Scientific Background Alpha synuclein is an abundant 140 amino acid neuronal protein, expressed primarily at presynaptic terminals in the central nervous system. Alpha synuclein has been associated with several neurodegenerative diseases. A point mutation in the gene coding for the alpha-synuclein protein was the first discovery linking this protein to a rare familial form of Parkinson's disease (PD). Subsequently, other mutations in the alpha-synuclein gene have been identified in familial PD. The aggregated proteinaceous inclusions called Lewy bodies found in PD and cortical Lewy body dementia (LBD) were discovered to be predominantly alpha-synuclein. Aberrant aggregation of alpha-synuclein has been detected in an increasing number of neurodegenerative diseases, collectively known as synucleopathies. Alpha-synuclein exists physiologically in both soluble and membrane-bound states, in unstructured and alpha-helical conformations, respectively. The physiological function of alpha-synuclein appears to require its translocation between these subcellular compartments and interconversion between the 2 conformations. Abnormal processing of alpha-synuclein is predicted to lead to pathological changes in its binding properties and function.
  • Shipping Temperature 25°C (ambient)
  • UNSPSC CODE 41116161
  • Regulatory Status For research use only.

    Images, Protocols & SDS

  • Immunohistochemical staining (paraffin-embedded tissue) of glial inclusions in white matter from a case of multiple system atrophy using sheep polyclonal to human alpha synuclein, catalogue number S-075-50.

  • Analysis of _-synuclein expression in formalin-fixed paraffin-embedded (FFPE) human Substantia Nigra tissue by Immunohistochemistry (IHC) using sheep antibody to _-synuclein (S-075-50, 4 µg/mL). Sections were cut to 4 um thickness and antigen retrieval performed using citrate buffer, pH 6, for 20 minutes. Primary antibody binding was visualized with a donkey anti-sheep-HRP conjugated secondary antibody (1:100) and 3'3-diaminobenzidine (DAB, brown). Cell nuclei were stained with a Hematoxylin nuclear counterstain (blue).


    Immunohistochemical staining of lewy body in Parkinsons diseased human brain tissue using sheep polyclonal to human alpha synuclein, catalogue number S-075-50.


    Analysis of alpha-synuclein expression by Flow Cytometry (A), Immunocytochemistry (B) and Western Blotting (C). The Flow Cytometry histogram (A) demonstrates presence of alpha-synuclein (blue line) in human SHSY-5Y neuroblastoma cells. Specific alpha-synuclein immunoreactivity (IR) is also observed in SHSY-5Y cells by Immunocytochemistry (B1, green), while under control conditions (B2), alpha-synuclein-IR is absent. In rodent tissue, the antibody detects _-synuclein monomer (~15 kDa) and a band at ~50 kDa on the blot, which most likely represents multimeric _-synuclein protein, which has been described by Shen et al., 2015, and others. Both bands are _-synuclein antibody specific as demonstrated by blocking with immunizing peptide. Recombinant human _-synuclein protein (100 ng) was run as control. Flow Cytometry method: Fixing and permeabilization: Absolute methanol (10 minutes on ice) and 0.1% Tween-20 in PBS; Blocking: 200 µg/mL sheep IgG; Primary antibody: sheep antibody to alpha-synuclein (S-075-50, 2 µg per ~10^6 cells, blue) for 30 minutes at room temperature; Secondary antibody: Goat anti-sheep, PE-labeled (1:100 dilution), 20 minutes in dark at room temperature. Negative control: Normal sheep IgG (S-1754-500, black). Data and results were generated using Orflo MoxiflowTM instrument and protocols. Immunocytochemistry method: Fixed (4% formaldehyde), permeabilized, and blocked (10% normal horse serum, 0.1% Triton X100) cells were incubated with alpha-synuclein antibody S-075-50 (2 µg/mL, green) for 1 hour. Primary antibody binding was visualized with a secondary donkey anti-sheep-CF488A antibody (4 µg/mL, 1 hour incubation). Cell nuclei were stained with Hoechst dye (blue). Control cells were stained following the same protocol, substituting the primary antibodies with normal sheep IgG (S-1754-500). Magnification: 100x. Western Blotting method: Protein loading amount: 50 µg per lane; Transfer: Towbin's buffer with 20% methanol, semi-dry; Blocking: 5% skim milk; Primary antibody: 1 µg/mL, overnight incubation at 2-8°C; Secondary antibody: anti-sheep-HRP (1:6000); Detection: Chemiluminiscence. Proteins were fixed on membrane (0.4% formaldehyde, 30 minutes at room temperature) after transfer as described by Lee & Kamitani, 2011.